Viewing Study NCT00626860


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2026-03-11 @ 5:02 PM
Study NCT ID: NCT00626860
Status: COMPLETED
Last Update Posted: 2017-03-28
First Post: 2008-02-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma
Sponsor: Beth Israel Deaconess Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2001P001112
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View